Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / exhibit-e-insurance-requirements.docx
exhibit-e-insurance-requirements.docx
Parties
Penterra Pharmaceuticals Corp
Liability Insurance Penterra Pharmaceuticals Corp
M. Best Company
M. Best
Clinical Affairs Penterra Pharmaceuticals Corp
Harkness LLP
Halcyon Partners LLC
M. Best Rating
Dates
June 28, 2023
April 1, 2023
March 31, 2024
July 19, 2023
July 5, 2023
Amounts
$25,000,000
$75,000,000
$10,000,000
$50,000,000
$5,000,000
$1,000,000
$500,000
$15,000,000
Obligations
Protocol: Protocol PPC-4871-III ("CLARION" — Clinical Assessment of Response with Longitudinal Investigation in ONcology) Investigational Product: Penterafenib (PPC-4871) Capitalized terms used but not otherwise defined in this Exhibit E shall have the meanings ascribed to them in the Agreement
1 shall be procured from and maintained with an insurance carrier rated A- (Excellent) or better by A
Sponsor shall ensure that the carrier's financial size category, as determined by A
The clinical trial liability coverage shall be written on an occurrence basis
The cost of any extended reporting period endorsement shall be borne solely by Sponsor
The subject-injury sublimit is intended to correspond to and support Sponsor's obligations under Exhibit D (Subject-Injury Indemnification Provisions) of the Agreement, and the scope and application of this sublimit shall be interpreted consistently with the provisions of Exhibit D